Artiva Biotherapeutics

(NASDAQ) ARTV

Current Price$10.63

Market Cap$259.53M

Since IPO (2024)-13%

5 YearN/A

1 Year+490%

1 Month+43%

Artiva Biotherapeutics Financials at a Glance

Market Cap

$259.53M

Revenue (TTM)

$0.00

Net Income (TTM)

$87.07M

EPS (TTM)

$-3.55

P/E Ratio

-2.96

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$10.63

Volume

389,693.1

Open

$11.38

Price

$10.63

Volume

389,693.1

Open

$11.38

Previous Close

$10.68

Daily Range

$10.25 - $11.50

52-Week Range

$1.47 - $14.53

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$10.63

Volume

389,693.1

Open

$11.38

Previous Close

$10.68

Daily Range

$10.25 - $11.50

52-Week Range

$1.47 - $14.53

ARTV News

Artiva (ARTV) Q2 Loss Widens 19.7%

Motley Fool Markets TeamAug 6, 2025

This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment

Leo MillerAug 29, 2024

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Artiva Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

104

CEO

Fred Aslan, MD, MBA

Website

www.artivabio.com

Headquarters

San Diego, CA 92121, US

ARTV Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-68%

Return on Capital

-97%

Return on Assets

-82%

Earnings Yield

-33.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$259.53M

Shares Outstanding

24.72M

Volume

389.69K

Avg. Volume

342.32K

Financials (TTM)

Gross Profit

$2.60M

Operating Income

$90.61M

EBITDA

$88.01M

Operating Cash Flow

$76.75M

Capital Expenditure

$2.59M

Free Cash Flow

$79.34M

Cash & ST Invst.

$108.01M

Total Debt

$10.94M

Artiva Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$666.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$259.53M

N/A

Market Cap/Employee

$2.70M

N/A

Employees

N/A

Net Income

$23.52M

-15.8%

EBITDA

$23.76M

-10.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$76.52M

-49.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$7.23M

-29.7%

Short Term Debt

$3.04M

-18.4%

Return on Assets

-82.18%

N/A

Return on Invested Capital

-96.84%

N/A

Free Cash Flow

$21.19M

-4.1%

Operating Cash Flow

$20.95M

-5.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZNTLZentalis Pharmaceuticals, Inc.

ZNTLZentalis Pharmaceuticals, Inc.$4.09-4.44%

STTKShattuck Labs, Inc.

STTKShattuck Labs, Inc.$6.67-1.19%

STROSutro Biopharma, Inc.

STROSutro Biopharma, Inc.$38.42-2.98%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$2.38-5.56%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.48+1.22%

ALXOALX Oncology Holdings Inc.

ALXOALX Oncology Holdings Inc.$2.04+0.49%

DTILPrecision BioSciences, Inc.

DTILPrecision BioSciences, Inc.$8.11-2.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$11.21+0.27%

FFord Motor Company

FFord Motor Company$14.48+0.07%

AIIORobo.ai

AIIORobo.ai$5.64+1.16%

NOKNokia

NOKNokia$14.46-0.02%

POETPoet Technologies

POETPoet Technologies$20.57+0.43%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.65-0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.70-0.00%

Questions About ARTV

What is the current price of Artiva Biotherapeutics?

Artiva Biotherapeutics is trading at $10.68 per share.

What is the 52-week range for Artiva Biotherapeutics?

Over the past 52 weeks, Artiva Biotherapeutics has traded between $1.47 and $14.53.

How much debt does Artiva Biotherapeutics have?

As of the most recent reporting period, Artiva Biotherapeutics reported total debt of $10.26M.

How much cash does Artiva Biotherapeutics have on hand?

Artiva Biotherapeutics reported $20.95M in cash and cash equivalents in its most recent financial results.

What is Artiva Biotherapeutics’s dividend yield?

Artiva Biotherapeutics does not currently have a dividend yield.

Artiva Biotherapeutics

Artiva Biotherapeutics Financials at a Glance

ARTV News

Artiva (ARTV) Q2 Loss Widens 19.7%

This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Artiva Biotherapeutics

ARTV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Artiva Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARTV

What is the current price of Artiva Biotherapeutics?

What is the 52-week range for Artiva Biotherapeutics?

How much debt does Artiva Biotherapeutics have?

How much cash does Artiva Biotherapeutics have on hand?

What is Artiva Biotherapeutics’s dividend yield?

Premium Investing Services